Resultado de búsqueda
Hace 5 días · Abstract. In 2022, 81,806 opioid-involved overdose deaths were reported in the United States, more than in any previous year. Medications for opioid use disorder (OUD), particularly buprenorphine and methadone, substantially reduce overdose-related and overall mortality. However, only a small proportion of persons with OUD receive these ...
Hace 4 días · Most respondents either did not know a PCP could treat people with an opioid use disorder (OUD) by prescribing MOUD (61.4% weighted) or incorrectly believed a PCP could not (13.3% weighted). Most respondents agreed (658 [53.9%]) or strongly agreed (309 [24.9%]) that a PCP office should be a place where people can receive OUD treatment ( Table 2 ).
Hace 3 días · People with an opioid use disorder are often treated with opioid replacement therapy using methadone or buprenorphine. Such treatment reduces the risk of death.
Hace 4 días · News Release. Friday, June 28, 2024. Most Americans don’t know that primary care physicians can prescribe addiction treatment. NIH-supported study reveals crucial need to increase public awareness that medications for opioid use disorder can be prescribed in primary care settings.
Hace 5 días · Just 25% of people battling opioid use disorder are getting medications aimed at helping them quit and potentially avoid an overdose, new data shows. Boosting access to proper treatment might save ...
Hace 5 días · THURSDAY, June 27, 2024 (HealthDay News) -- Just 25% of people battling opioid use disorder are getting medications aimed at helping them quit and potentially avoid an overdose, new data shows....
Hace 4 días · PROVIDENCE, R.I. [Brown University] — Most Americans don’t realize that primary care physicians can prescribe medication for opioid use disorder, according to a recent national survey of more than 1,000 people. These perceptions are significant considering the efforts that have been made to lower the barriers to treatment of opioid use disorder, said lead study author Brandon del Pozo, an ...
